Huons

243070 · KOSDAQ · Health Care · SMALL CAP

Provisional Q4 2025 results.

Huons filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$115M (+12.7% year on year), operating profit of US$6.83M (−10.6% year on year) and net income of US$6.4M (+135% year on year).

Earnings(Operating results (consolidated) (preliminary) (fair disclosure))· FILED 2026-02-13· RCEPT 20260213901168

US$115MRevenue
+12.7%Revenue vs a year earlier
US$6.83MOperating profit

Converted at 1 USD ≈ ₩1,440.9 (filing-date rate, 2026-02-13 close)

What happened

Huons filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$115M (+12.7% year on year), operating profit of US$6.83M (−10.6% year on year) and net income of US$6.4M (+135% year on year).

These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.

RevenueUS$115M
Revenue vs a year earlier+12.7%
Operating profitUS$6.83M
Net incomeUS$6.4M
PeriodQ4 2025 (consolidated)
Filed2026-02-13, Operating results (consolidated) (preliminary) (fair disclosure)
SourceDART rcept 20260213901168 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-02-13 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.